SENS — Senseonics Holdings, Inc.

Nasdaq · Unknown · Unknown · CIK 1616543 ·
Last close
$6.43
Market Cap
$335.67M
52W High
$8.45
52W Low
$4.79
ADV30
1,013,857
Next earnings
2026-08-06
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 11,711,000 6,940,000 -31,846,000 -32,333,000 102,857,000 29,612,000 68,522,000
Dec 2025 14,256,000 7,669,000 -20,925,000 -20,823,000 126,269,000 40,234,000 65,223,000
Sep 2025 8,095,000 3,468,000 -19,601,000 -19,530,000 139,924,000 34,458,000 61,759,000
Jun 2025 6,649,000 3,121,000 -14,323,000 -14,501,000 150,274,000 31,518,000 55,554,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-59,129,000
Investing CF
$-53,422,000
Financing CF
$78,188,000
CapEx
$-1,116,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.27
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,016,987,000
Inventory
$6,703,000
Receivables
$12,430,000
ST Investments
$53,796,000
EBIT TTM
$-64,162,000
Pretax Income TTM
$-69,113,000
Interest Exp TTM
$4,951,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$40,711,000
EBITDA
$-85,189,000
Free Cash Flow
Enterprise Value
$246,620,848
Total Cash
$64,321,000
Total Debt
$42,197,000
Shares Out
52,202,965
Trailing EPS
$-1.97
Book Value
$0.82
ROE
-250.8%
ROA
-57.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 35,257,000 -68,337,000 -69,113,000 126,269,000 65,223,000 -59,129,000
Dec 2024 22,472,000 -74,842,000 -78,616,000 100,438,000 116,993,000 -60,465,000
Dec 2023 22,390,000 -75,603,000 -60,392,000 138,220,000 102,424,000 -70,163,000
Dec 2022 16,389,000 -68,627,000 142,119,000 177,673,000 180,249,000 -66,312,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$1,659
OpCashFlow TTM
$0
Assets (Latest)
$10,000
Forward EPS
$-2.27

News headlines (Yahoo Finance, 1h cache)

Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
2026-05-09 01:06 · Yahoo
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 21:55 · Yahoo
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
2026-05-07 20:01 · Yahoo
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2026-05-04 20:01 · Yahoo
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
2026-05-04 12:00 · Yahoo
Top Midday Decliners
2026-05-01 18:06 · Yahoo
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
2026-05-01 13:10 · Yahoo
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
2026-04-30 20:01 · Yahoo
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
2026-04-24 11:00 · Yahoo
Study Supports GlucoTrack’s Blood Glucose Monitoring Implant
2026-04-21 15:59 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.